Secondary Stock OfferingsBy The Online Investor Staff, updated Sat., Sep. 19, 7:58 AM
|This Slide: #16 of 25|
Slide #16. 10x Genomics, Inc. — Secondary Offering
10x Genomics, Inc. (NASDAQ:TXG)
Date of Pricing:
Price Per Share:
Secondary Offering Details:
10x Genomics, Inc. (NASDAQ: TXG) (the "Company") today announced the pricing of an upsized underwritten public offering by the Company of its Class A common stock at a price to the public of $110.00 per share, before underwriting discounts and commissions. 10x Genomics is offering 4,000,000 shares of its Class A common stock, plus up to an additional 600,000 shares of its Class A common stock that the underwriters have the right to purchase at the public offering price, less the underwriting discounts and commissions. All of the shares are being offered by the Company. The offering is expected to close on September 15, 2020, subject to customary closing conditions.
10x Genomics is a life science technology company building products to interrogate, understand and master biology. Co.'s product portfolio consists of multiple integrated solutions that include instruments, consumables and software. Co.'s Chromium platform, which includes its Chromium Controllers, microfluidic chips and related consumables, enables high-throughput analysis of individual biological components. Co.'s Visium platform enables researchers to understand the spatial positions of biological analytes within tissues at high resolution. Co.'s software is a part of its integrated solutions and is comprised of two parts, analysis and visualization.
TXG SEC Filing Email Alerts Service
Open the TXG Page at The Online Investor »
Strong Buy (3.94 out of 4)
(ranked higher than approx. 79% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite